Brensocatib

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status 
Brensocatib 2923839-30-7 Mar, 2027  Mar.12, 2035 estimated PV Completion – Dec, 2026

 

[Indication] 

  • For the treatment of non-cystic fibrosis bronchiectasis (NCFB) in patients 12 years of age and older.


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us

    Products categories